Unfold CFO Tools

Warrant: equity or liability?

ASC 815-40 in the two steps it actually is — indexation first, then the conditions. Which one fails decides whether it can be drafted away.

🔒 Your numbers stay in your browser. We never store your raw financials unless you explicitly save them.
Step 1

Is it indexed to your own stock?

ASC 815-40-15. Fail here and the analysis ends — the additional conditions are never reached.

Does the settlement amount differ depending on who holds the warrant?
Does the exercise price or share count adjust for anything beyond standard anti-dilution?
Step 2

Would it be classified in equity?

ASC 815-40-25. Failures here are often drafting rather than economics, which sometimes means they can be amended.

Can a tender offer or change of control require the warrant to be cash settled?
Could the entity be required to net cash settle in any circumstance outside its control?
Are there enough authorised and unissued shares to settle in every case?
Does the contract cap the number of shares deliverable?

A structured read of the fact patterns that most often decide this. Not an accounting conclusion; the analysis belongs in a memo with the warrant agreement attached.

Two steps, and which one fails decides what you can do about it

In April 2021 several hundred companies restated their financial statements because warrants they had classified in equity turned out to belong in liabilities. The striking thing about that wave was not that the analysis was hard — it was that most of those companies had never done it. The warrant agreement came from a template, the classification came from what everybody else did, and nobody read the two clauses that mattered until the Commission staff wrote them down.

The first was settlement that varied with the identity of the holder: private placement warrants whose terms changed if they left the sponsor group. That fails at the first step, indexation, because the person holding an instrument is not one of the inputs you price a fixed-for-fixed option on. The second was a tender offer provision that could hand the warrant holder cash in a scenario where ordinary shareholders got none, which falls outside the narrow exception that permits equity treatment for change-of-control settlement.

Knowing which step fails is more useful than knowing the answer. Indexation failures are about what the instrument economically is, and redrafting will not save them without changing the commercial deal. Failures on the additional conditions are often a single sentence that nobody negotiated and nobody would defend — and a sentence can be amended, which is enormously cheaper before the financial statements go out than after.

One consequence is worth understanding before it appears in your results rather than after. A warrant liability is marked to fair value every period, and that value moves with your own share price. A good quarter in the market shows up as a loss. It is non-cash, it is entirely mechanical, and it will be the first thing somebody asks about on the call.

What this tool does not do

It asks about the fact patterns that decide this in practice, not about every condition in the standard. The two conclusions drawn from the SEC staff statement on SPAC warrants are quoted from that statement and marked SEC-sourced on screen. Everything else is marked 'text not read', because the full set of additional conditions in ASC 815-40-25 sits in the FASB Codification behind a login this tool does not pass - so it names the conditions rather than reproducing paragraph text it has not seen. Check those against the Codification before anything depends on them.

  • The complete list of additional conditions in ASC 815-40-25 - it asks about the decisive ones and says so
  • Reading your warrant agreement, which is where every one of these answers actually lives
  • Measuring fair value, selecting a valuation model, or anything about what the liability is worth once classified
  • Down-round features, ASU 2017-11, or the interaction with convertible instruments under ASU 2020-06
  • Whether an amendment would fix the problem, or what amending it does to the holders' rights and to the deal
  • Modification and extinguishment accounting if you do amend it
  • Your auditor's conclusion and your technical accounting memo, which are the actual deliverables here

Frequently asked questions

Why is this two steps rather than one test?

Because ASC 815-40 is two questions. First, is the instrument indexed to the entity's own stock. Only if it is do you reach the additional conditions for equity classification. Both failures give the same accounting answer, but they are different problems: an indexation failure is usually structural and cannot be drafted away, while a failure on the conditions is often a template clause nobody negotiated — and that can sometimes be amended.

What actually caused the 2021 SPAC warrant restatements?

Two fact patterns the SEC staff identified. One was settlement amounts that varied depending on who held the warrant — which fails indexation, because in the staff's words the holder "is not an input into the pricing of a fixed-for-fixed option on equity shares." The other was tender offer provisions that could pay the warrant holder cash in circumstances where ordinary shareholders might not receive cash, which falls outside the change-of-control exception.

Why does a rising share price create a loss?

Because a warrant liability is remeasured at fair value through earnings every period, and the fair value of a warrant on your own shares rises when your shares rise. So good news in the market becomes a charge in the income statement. It is entirely non-cash and that does not stop anyone asking about it — explaining that line is a recurring cost of getting the classification wrong.

Why does the tool say 'text not read' on some conditions?

Because it is true, and the alternative was to reproduce paragraph text from memory. The full list of additional conditions in ASC 815-40-25 sits in the FASB Codification, behind a login this tool does not pass. The two SEC-sourced conclusions carry their quotes because those come from a public Commission statement that was actually fetched. Presenting both at the same confidence would have been the dishonest option, and a test in the build fails if any unfetched text is ever quoted.

We have enough authorised shares today. Is that settled?

No, and this is the condition most likely to lapse without anyone touching the warrant. Sufficiency is tested against everything that could require share issuance, so a convertible instrument issued later, an enlarged option pool, or another warrant tranche can break it. An instrument that met the condition at issuance can stop meeting it a year later while its own terms are unchanged.